Stratec Biomedical AG | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
21,380.00
47,513.00
59,073.00
32,195.00
36,635.00
23,816
Total Accounts Receivable
29,012.00
23,823.00
32,054.00
48,105.00
50,306.00
39,901
Inventories
18,091.00
18,066.00
16,019.00
24,519.00
27,880.00
58,530
Other Current Assets
845.00
607.00
162.00
-
-
3,234
Total Current Assets
69,328.00
90,009.00
107,308.00
104,819.00
114,821.00
125,481
Net Property, Plant & Equipment
17,013.00
15,954.00
19,595.00
32,789.00
35,701.00
39,510
Total Investments and Advances
392.00
263.00
184.00
378.00
240.00
459
Intangible Assets
30,188.00
30,262.00
30,992.00
118,776.00
110,726.00
98,262
Other Assets
-
-
839.00
1,106.00
2,160.00
2,815
Total Assets
117,788.00
137,748.00
161,817.00
261,195.00
269,022.00
284,327
ST Debt & Current Portion LT Debt
1,894.00
2,449.00
3,816.00
69,008.00
971.00
Accounts Payable
4,402.00
2,814.00
3,436.00
7,100.00
6,928.00
Income Tax Payable
857.00
1,410.00
1,502.00
325.00
2,176.00
Other Current Liabilities
5,410.00
8,913.00
9,913.00
17,764.00
18,624.00
Total Current Liabilities
12,563.00
15,586.00
18,667.00
94,197.00
28,699.00
Long-Term Debt
6,643.00
4,483.00
4,328.00
2,505.00
61,534.00
Provision for Risks & Charges
14.00
61.00
63.00
3,386.00
3,402.00
Deferred Taxes
522.00
4,307.00
5,558.00
14,475.00
10,907.00
Other Liabilities
-
-
22.00
964.00
1,269.00
Total Liabilities
20,609.00
25,697.00
31,537.00
118,854.00
111,185.00
Common Equity (Total)
97,179.00
112,051.00
130,280.00
142,341.00
157,837.00
Total Shareholders' Equity
97,179.00
112,051.00
130,280.00
142,341.00
157,837.00
Total Equity
97,179.00
112,051.00
130,280.00
142,341.00
157,837.00
Liabilities & Shareholders' Equity
117,788.00
137,748.00
161,817.00
261,195.00
269,022.00

About Stratec Biomedical

View Profile
Address
Gewerbestrasse 37
Birkenfeld Rheinland-Pfalz 75217
Germany
Employees -
Website http://www.stratec.com
Updated 07/08/2019
STRATEC Biomedical AG engages in the design and manufacture of automated analyzer systems in the field of clinical diagnostic and biotechnology. It operates through the following segments: Instrumentation, Diatron, Consumables, and Other Activities. The Instrumentation segment refers to the design and manufacture of fully automated analyzer systems for its clinical diagnostic and biotechnology customers.